European Medicines Agency update to guidance on regulatory expectations in the context of COVID-19 pandemic

The updated guidance states validity of GMP certificates and time-limited manufacturing/import authorisations, as well as validity of GDP certificates and time-limited wholesale authorisations will be extended until end of 2021 in order to mitigate impact of supply disruptions.


European Medicines Agency